Latest News

Indian Sofosbuvir & Velpatasvir Tablets

Epclusa : New Hepatitis C Drug Treatment Medicine . Gilead Sciences will allow seven large Indian generic drug producers to make and sell its blockbuster hepatitis C drug in more than 90 developing countries, in a move it says will ensure affordable access to the potentially...

Natco introduces Indian Eribulin Mesylate Injection under the Trade name Ebunat 0.5mg

Natco recently launched (E7389) Eribulin 0.5mg Injection (Ebunat Injection) and EISAI Halaven 0.44mg/mL Injection Natco has become a pre-eminent organization in terms of launching new generics alternatives and introducing to the rest of the world that how with the same...

Natco launches Indian Stivarga Regorafenib 40mg Tablets under the brand name Regonat 40mg Tablets

Regonat 40mg Tablets: Generic version of Regorafenib Tablets now available in India Natco Pharma Limited has become the foremost Pharmaceutical Company in India who has launched the first generic version of Bayer AG invented drug Stivarga Regorafenib 40mg Tablets under...

Exelixis initiates Phase III trial of cabozantinib to treat (RCC) Renal Cell Carcinoma

Exelixis is commencing a Phase III pivotal trial to evaluate cabozantinib (CABOMETYX) for the treatment of patients with previously untreated advanced renal cell carcinoma (RCC). As part of the trial, cabozantinib will be evaluated in combination with nivolumab (Opdivo) and...

Natco India settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib

Natco has partnered with Breckenridge Pharmaceutical, which will market the product in the US. Indian Drug maker Natco Pharma on May 30th, 2019 said it has reached an out-of-court settlement in the US with Onyx Therapeutics over patent litigation related to the generic...